Rapid Micro Biosystems
RPID
59 hedge funds and large institutions have $181M invested in Rapid Micro Biosystems in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 9 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
11.01% more ownership
Funds ownership: 62.22% → 73.23% (+11%)
7% more funds holding
Funds holding: 55 → 59 (+4)
21% less capital invested
Capital invested by funds: $228M → $181M (-$46.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLM
Kennedy Lewis Management
New York
|
+$11.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.19M |
| 3 |
AWGLSCP
ABG-WTT Global Life Science Capital Partners
Central, Hong Kong,
Hong Kong
|
+$7.65M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$4.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$2.95M |
| 2 |
PA
Perceptive Advisors
New York
|
-$1.44M |
| 3 |
JP Morgan Chase
New York
|
-$1.07M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.06M |
| 5 |
Goldman Sachs
New York
|
-$935K |
RPID Hedge Fund Activity: Q1 2022 in Review
59 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q1 2022, worth a combined $181M — down 21% from $228M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RPID positions and 9 closed out — a net gain of 4 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Kennedy Lewis Management, adding an estimated $11.1M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $2.95M sold.
- 59 institutional investors held Rapid Micro Biosystems (RPID) as of Q1 2022, up from 55 in Q4 2021.
- Funds reported $181M of Rapid Micro Biosystems stock for Q1 2022, down 21% quarter-over-quarter.
- 13 funds opened new Rapid Micro Biosystems positions in Q1 2022 and 9 closed out, a net change of +4 holders.
- The largest Rapid Micro Biosystems buyer in Q1 2022 was Kennedy Lewis Management, an estimated $11.1M added.
- The largest Rapid Micro Biosystems seller in Q1 2022 was Pura Vida Investments, an estimated $2.95M sold.
Based on aggregated 13F filings for Q1 2022.